<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Weiss PF</submitter><funding>National Institute of Arthritis and Musculoskeletal and Skin Diseases</funding><funding>Intramural NIH HHS</funding><funding>NIAMS NIH HHS</funding><pagination>1797-1808</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11606790</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>76(12)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>The goal was to develop and validate classification criteria for axial juvenile spondyloarthritis (SpA; AxJSpA).&lt;h4>Methods&lt;/h4>This international initiative consisted of four phases: (1) item generation, (2) item reduction, (3) criteria development, and (4) validation of the AxJSpA criteria by an independent team of experts in an internationally representative validation cohort.&lt;h4>Results&lt;/h4>These criteria are intended to be used on youth with a physician diagnosis of juvenile SpA and for whom axial disease is suspected. Item generation consisted of a systematic literature review and a free-listing exercise using input from international physicians, which collectively resulted in 108 items. After the item reduction exercise and expert panel input, 37 items remained for</pubmed_abstract><journal>Arthritis &amp; rheumatology (Hoboken, N.J.)</journal><pubmed_title>Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis.</pubmed_title><pmcid>PMC11606790</pmcid><funding_grant_id>R01 AR073201</funding_grant_id><funding_grant_id>1R01AR074098</funding_grant_id><funding_grant_id>AR041184</funding_grant_id><funding_grant_id>R01 AR074098</funding_grant_id><funding_grant_id>R01AR073201</funding_grant_id><funding_grant_id>ZIA AR041184</funding_grant_id><funding_grant_id>P30AR070253</funding_grant_id><funding_grant_id>P30 AR070253</funding_grant_id><pubmed_authors>Maksymowych WP</pubmed_authors><pubmed_authors>Minden K</pubmed_authors><pubmed_authors>Weiss PF</pubmed_authors><pubmed_authors>Klein-Gitelman MS</pubmed_authors><pubmed_authors>Tse SM</pubmed_authors><pubmed_authors>Stoll ML</pubmed_authors><pubmed_authors>Naden R</pubmed_authors><pubmed_authors>Colbert RA</pubmed_authors><pubmed_authors>Kasapcopur O</pubmed_authors><pubmed_authors>Ozen S</pubmed_authors><pubmed_authors>Horneff G</pubmed_authors><pubmed_authors>Brandon TG</pubmed_authors><pubmed_authors>Ravelli A</pubmed_authors><pubmed_authors>Hendry AM</pubmed_authors><pubmed_authors>Lovell DJ</pubmed_authors><pubmed_authors>Smith JA</pubmed_authors><pubmed_authors>Biko DM</pubmed_authors><pubmed_authors>Jaremko JL</pubmed_authors><pubmed_authors>Francavilla ML</pubmed_authors><pubmed_authors>Herregods N</pubmed_authors><pubmed_authors>Van den Bosch F</pubmed_authors><pubmed_authors>Ruperto N</pubmed_authors><pubmed_authors>Foeldvari I</pubmed_authors><pubmed_authors>Lambert RG</pubmed_authors><pubmed_authors>Nigrovic PA</pubmed_authors><pubmed_authors>Joos R</pubmed_authors><pubmed_authors>Yildiz M</pubmed_authors><pubmed_authors>Laxer RM</pubmed_authors><pubmed_authors>Burgos-Vargas R</pubmed_authors><pubmed_authors>Aggarwal A</pubmed_authors><pubmed_authors>Chauvin NA</pubmed_authors><pubmed_authors>Srinivasalu H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis.</name><description>&lt;h4>Objective&lt;/h4>The goal was to develop and validate classification criteria for axial juvenile spondyloarthritis (SpA; AxJSpA).&lt;h4>Methods&lt;/h4>This international initiative consisted of four phases: (1) item generation, (2) item reduction, (3) criteria development, and (4) validation of the AxJSpA criteria by an independent team of experts in an internationally representative validation cohort.&lt;h4>Results&lt;/h4>These criteria are intended to be used on youth with a physician diagnosis of juvenile SpA and for whom axial disease is suspected. Item generation consisted of a systematic literature review and a free-listing exercise using input from international physicians, which collectively resulted in 108 items. After the item reduction exercise and expert panel input, 37 items remained for</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2026-06-06T07:22:03.518Z</modification><creation>2026-06-06T03:07:22.368Z</creation></dates><accession>S-EPMC11606790</accession><cross_references><pubmed>39039899</pubmed><doi>10.1002/art.42959</doi></cross_references></HashMap>